UNILEVER
PLC
|
|
/S/ M VARSELLONA
|
BY M VARSELLONA
|
CHIEF LEGAL OFFICER AND GROUP SECRETARY
|
EXHIBIT
NUMBER
|
EXHIBIT
DESCRIPTION
|
99
|
Notice
to London Stock Exchange dated 13 February 2025
|
|
Final
Results
|
Improved performance led by volume growth and gross margin
expansion
|
Underlying performance
|
|
|
GAAP measures
|
||||
(unaudited)
|
2024
|
vs 2023
|
|
|
|
2024
|
vs 2023
|
Full Year
|
|
|
|
|
|
|
|
Underlying sales growth (USG)
|
|
4.2%
|
|
|
Turnover
|
€60.8bn
|
1.9%
|
Beauty
& Wellbeing
|
|
6.5%
|
|
|
Beauty
& Wellbeing
|
€13.2bn
|
5.5%
|
Personal
Care
|
|
5.2%
|
|
|
Personal
Care
|
€13.6bn
|
(1.5)%
|
Home
Care
|
|
2.9%
|
|
|
Home
Care
|
€12.3bn
|
1.4%
|
Foods(a)
|
|
2.6%
|
|
|
Foods(a)
|
€13.4bn
|
1.1%
|
Ice
Cream
|
|
3.7%
|
|
|
Ice
Cream
|
€8.3bn
|
4.5%
|
Underlying operating profit
|
€11.2bn
|
12.6%
|
|
|
Operating profit
|
€9.4bn
|
(3.7)%
|
Underlying operating margin
|
18.4%
|
170bps
|
|
|
Operating margin
|
15.5%
|
(90)bps
|
Underlying earnings per share
|
€2.98
|
14.7%
|
|
|
Diluted earnings per share
|
€2.29
|
(10.6)%
|
Free cash flow
|
€6.9bn
|
€(0.2)bn
|
|
|
Net profit
|
€6.4bn
|
(10.8)%
|
Fourth Quarter
|
|
|
|
|
|
|
|
USG
|
|
4.0%
|
|
|
Turnover
|
€14.2bn
|
(0.1)%
|
Quarterly dividend payable in March 2025
|
|
|
€0.4528
|
per share(b)
|
Outlook
|
Full Year Review: Unilever Group
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover
change
|
Full Year
|
€60.8bn
|
4.2%
|
2.9%
|
1.3%
|
(1.5)%
|
(0.7)%
|
1.9%
|
Fourth Quarter
|
€14.2bn
|
4.0%
|
2.7%
|
1.3%
|
(2.9)%
|
(1.1)%
|
(0.1)%
|
(unaudited)
|
UOP
|
UOP growth
|
UOM%
|
Change in
UOM
|
OP
|
OP growth
|
OM%
|
Change in
OM
|
Full Year
|
€11.2bn
|
12.6%
|
18.4%
|
170bps
|
€9.4bn
|
(3.7)%
|
15.5%
|
(90)bps
|
Conference Call
|
Upcoming Events
|
Date
|
Events
|
24 April 2025
|
Q1 2025 trading statement
|
Full Year Review: Business Groups
|
|
Full Year 2024
|
Fourth Quarter 2024
|
||||||||
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
UOM
|
Change in
UOM
|
Turnover
|
USG
|
UVG
|
UPG
|
Unilever
|
€60.8bn
|
4.2%
|
2.9%
|
1.3%
|
18.4%
|
170bps
|
€14.2bn
|
4.0%
|
2.7%
|
1.3%
|
Beauty
& Wellbeing
|
€13.2bn
|
6.5%
|
5.1%
|
1.3%
|
19.4%
|
70bps
|
€3.3bn
|
5.2%
|
3.9%
|
1.2%
|
Personal
Care
|
€13.6bn
|
5.2%
|
3.1%
|
2.1%
|
22.1%
|
190bps
|
€3.3bn
|
5.3%
|
3.6%
|
1.6%
|
Home
Care
|
€12.3bn
|
2.9%
|
4.0%
|
(1.1)%
|
14.5%
|
220bps
|
€3.0bn
|
3.0%
|
3.3%
|
(0.3)%
|
Foods
|
€13.4bn
|
2.6%
|
0.2%
|
2.4%
|
21.3%
|
270bps
|
€3.4bn
|
2.6%
|
0.5%
|
2.1%
|
Ice
Cream
|
€8.3bn
|
3.7%
|
1.6%
|
2.1%
|
11.8%
|
100bps
|
€1.2bn
|
4.3%
|
2.2%
|
2.0%
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover
change
|
UOM%
|
Change in
UOM
|
Full Year
|
€13.2bn
|
6.5%
|
5.1%
|
1.3%
|
(0.3)%
|
(0.6)%
|
5.5%
|
19.4%
|
70bps
|
Fourth Quarter
|
€3.3bn
|
5.2%
|
3.9%
|
1.2%
|
(0.7)%
|
(0.4)%
|
4.1%
|
|
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover
change
|
UOM%
|
Change in
UOM
|
Full Year
|
€13.6bn
|
5.2%
|
3.1%
|
2.1%
|
(5.3)%
|
(1.1)%
|
(1.5)%
|
22.1%
|
190bps
|
Fourth Quarter
|
€3.3bn
|
5.3%
|
3.6%
|
1.6%
|
(8.1)%
|
(1.7)%
|
(5.0)%
|
|
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover
change
|
UOM%
|
Change in
UOM
|
Full Year
|
€12.3bn
|
2.9%
|
4.0%
|
(1.1)%
|
(0.9)%
|
(0.5)%
|
1.4%
|
14.5%
|
220bps
|
Fourth Quarter
|
€3.0bn
|
3.0%
|
3.3%
|
(0.3)%
|
(2.4)%
|
(1.0)%
|
(0.5)%
|
|
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover
change
|
UOM%
|
Change in
UOM
|
Full Year
|
€13.4bn
|
2.6%
|
0.2%
|
2.4%
|
(0.5)%
|
(1.0)%
|
1.1%
|
21.3%
|
270bps
|
Fourth Quarter
|
€3.4bn
|
2.6%
|
0.5%
|
2.1%
|
(0.7)%
|
(1.4)%
|
0.5%
|
|
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover
change
|
UOM%
|
Change in
UOM
|
Full Year
|
€8.3bn
|
3.7%
|
1.6%
|
2.1%
|
0.9%
|
(0.1)%
|
4.5%
|
11.8%
|
100bps
|
Fourth Quarter
|
€1.2bn
|
4.3%
|
2.2%
|
2.0%
|
(2.1)%
|
(0.3)%
|
1.8%
|
|
|
Full Year Review: Geographical Areas
|
|
Full Year 2024
|
Fourth Quarter 2024
|
||||||
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Turnover
|
USG
|
UVG
|
UPG
|
Unilever
|
€60.8bn
|
4.2%
|
2.9%
|
1.3%
|
€14.2bn
|
4.0%
|
2.7%
|
1.3%
|
Asia
Pacific Africa
|
€26.0bn
|
3.1%
|
1.8%
|
1.3%
|
€6.0bn
|
3.1%
|
1.4%
|
1.6%
|
The
Americas
|
€22.5bn
|
5.5%
|
4.0%
|
1.4%
|
€5.5bn
|
5.4%
|
3.9%
|
1.5%
|
Europe
|
€12.3bn
|
4.3%
|
3.0%
|
1.2%
|
€2.7bn
|
3.5%
|
3.4%
|
0.1%
|
|
Full Year 2024
|
Fourth Quarter 2024
|
||||||
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Turnover
|
USG
|
UVG
|
UPG
|
Emerging
markets
|
€35.3bn
|
4.1%
|
2.5%
|
1.5%
|
€8.1bn
|
3.0%
|
1.1%
|
1.9%
|
Developed
markets
|
€25.5bn
|
4.4%
|
3.3%
|
1.1%
|
€6.1bn
|
5.4%
|
5.1%
|
0.3%
|
North
America
|
€13.4bn
|
5.3%
|
4.1%
|
1.1%
|
€3.4bn
|
7.0%
|
6.5%
|
0.5%
|
Latin
America
|
€9.1bn
|
6.0%
|
3.9%
|
2.0%
|
€2.1bn
|
3.0%
|
-%
|
3.0%
|
Additional commentary on the financial statements - Full
Year
|
Non-GAAP measures
|
|
Annual
average rate in 2024
|
Annual
average rate in 2023
|
Brazilian Real (€1 = BRL)
|
5.761
|
5.405
|
Chinese Yuan (€1 = CNY)
|
7.751
|
7.635
|
Indian Rupee (€1 = INR)
|
90.652
|
89.232
|
Indonesia Rupiah (€1 = IDR)
|
17,177
|
16,457
|
Philippine Peso (€1 = PHP)
|
62.055
|
60.110
|
Mexican Peso (€1 = MXN)
|
19.589
|
19.169
|
Turkish Lira (€1 = TRY)
|
36.671
|
31.625
|
UK Pound Sterling (€1 = GBP)
|
0.848
|
0.870
|
US Dollar (€1 = US $)
|
1.085
|
1.081
|
(unaudited)
|
Beauty
& Wellbeing
|
Personal
Care
|
Home
Care
|
Foods
|
Ice
Cream
|
Total
|
Fourth Quarter
|
|
|
|
|
|
|
Turnover (€ million)
|
|
|
|
|
|
|
2023
|
3,181
|
3,404
|
2,974
|
3,416
|
1,202
|
14,177
|
2024
|
3,310
|
3,235
|
2,960
|
3,434
|
1,223
|
14,162
|
Turnover growth (%)
|
4.1
|
(5.0)
|
(0.5)
|
0.5
|
1.8
|
(0.1)
|
Effect of acquisitions (%)
|
0.9
|
-
|
-
|
-
|
-
|
0.2
|
Effect of disposals (%)
|
(1.6)
|
(8.1)
|
(2.4)
|
(0.7)
|
(2.1)
|
(3.2)
|
Effect of currency-related items (%), of which:
|
(0.4)
|
(1.7)
|
(1.0)
|
(1.4)
|
(0.3)
|
(1.1)
|
Exchange rates changes (%)
|
(1.8)
|
(3.9)
|
(3.8)
|
(3.4)
|
(0.4)
|
(3.0)
|
Extreme price growth in hyperinflationary markets* (%)
|
1.5
|
2.2
|
2.9
|
2.1
|
-
|
2.0
|
Underlying sales growth (%)
|
5.2
|
5.3
|
3.0
|
2.6
|
4.3
|
4.0
|
Full Year
|
|
|
|
|
|
|
Turnover (€ million)
|
|
|
|
|
|
|
2023
|
12,466
|
13,829
|
12,181
|
13,204
|
7,924
|
59,604
|
2024
|
13,157
|
13,618
|
12,352
|
13,352
|
8,282
|
60,761
|
Turnover growth (%)
|
5.5
|
(1.5)
|
1.4
|
1.1
|
4.5
|
1.9
|
Effect of acquisitions (%)
|
0.9
|
-
|
-
|
-
|
1.2
|
0.4
|
Effect of disposals (%)
|
(1.2)
|
(5.3)
|
(0.9)
|
(0.5)
|
(0.3)
|
(1.8)
|
Effect of currency-related items (%), of which:
|
(0.6)
|
(1.1)
|
(0.5)
|
(1.0)
|
(0.1)
|
(0.7)
|
Exchange rates changes (%)
|
(2.2)
|
(3.0)
|
(3.6)
|
(2.8)
|
(1.9)
|
(2.8)
|
Extreme price growth in hyperinflationary markets* (%)
|
1.6
|
1.9
|
3.2
|
1.9
|
1.8
|
2.1
|
Underlying sales growth (%)
|
6.5
|
5.2
|
2.9
|
2.6
|
3.7
|
4.2
|
(unaudited)
|
Asia
Pacific Africa
|
The
Americas
|
Europe
|
Total
|
Fourth Quarter
|
|
|
|
|
Turnover (€ million)
|
|
|
|
|
2023
|
6,119
|
5,388
|
2,670
|
14,177
|
2024
|
5,988
|
5,453
|
2,721
|
14,162
|
Turnover growth (%)
|
(2.1)
|
1.2
|
1.9
|
(0.1)
|
Effect of acquisitions (%)
|
-
|
0.6
|
-
|
0.2
|
Effect of disposals (%)
|
(3.8)
|
(2.8)
|
(2.5)
|
(3.2)
|
Effect of currency-related items (%), of which:
|
(1.3)
|
(1.8)
|
1.0
|
(1.1)
|
Exchange rates changes (%)
|
(2.5)
|
(5.4)
|
1.0
|
(3.0)
|
Extreme price growth in hyperinflationary markets* (%)
|
1.2
|
3.8
|
-
|
2.0
|
Underlying sales growth (%)
|
3.1
|
5.4
|
3.5
|
4.0
|
Full Year
|
|
|
|
|
Turnover (€ million)
|
|
|
|
|
2023
|
26,234
|
21,531
|
11,839
|
59,604
|
2024
|
25,991
|
22,491
|
12,279
|
60,761
|
Turnover growth (%)
|
(0.9)
|
4.5
|
3.7
|
1.9
|
Effect of acquisitions (%)
|
-
|
1.0
|
-
|
0.4
|
Effect of disposals (%)
|
(1.2)
|
(2.9)
|
(1.2)
|
(1.8)
|
Effect of currency-related items (%), of which:
|
(2.7)
|
0.9
|
0.7
|
(0.7)
|
Exchange rates changes (%)
|
(4.1)
|
(3.0)
|
0.7
|
(2.8)
|
Extreme price growth in hyperinflationary markets* (%)
|
1.5
|
4.0
|
-
|
2.1
|
Underlying sales growth (%)
|
3.1
|
5.5
|
4.3
|
4.2
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Non-underlying items within operating profit before
tax
|
(1,779)
|
(173)
|
Acquisition and disposal-related
costs(a)
|
(387)
|
(242)
|
(Loss)/gain disposal of group
companies(b)
|
(406)
|
489
|
Restructuring costs(c)
|
(850)
|
(499)
|
Impairments(d)
|
(133)
|
(1)
|
Other
|
(3)
|
80
|
Tax on non-underlying items within operating profit
|
129
|
207
|
Non-underlying items within operating profit after tax
|
(1,650)
|
34
|
Non-underlying items not in operating profit but within net profit
before tax
|
(155)
|
(153)
|
Interest
related to the UK tax audit of intangible income and centralised
services
|
40
|
(11)
|
Net
monetary loss arising from hyperinflationary economies
|
(195)
|
(142)
|
Tax impact of non-underlying items not in operating profit but
within net profit, including non-underlying tax items
|
90
|
12
|
Non-underlying items not in operating profit but within net profit
after tax
|
(65)
|
(141)
|
Non-underlying items after tax
|
(1,715)
|
(107)
|
Attributable to:
|
|
|
Non-controlling
interests
|
21
|
(6)
|
Shareholders'
equity
|
(1,736)
|
(101)
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Operating profit
|
9,400
|
9,758
|
Non-underlying items within operating profit
|
1,779
|
173
|
Underlying operating profit
|
11,179
|
9,931
|
Turnover
|
60,761
|
59,604
|
Operating margin (%)
|
15.5
|
16.4
|
Underlying operating margin (%)
|
18.4
|
16.7
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Taxation
|
2,500
|
2,199
|
Tax impact of:
|
|
|
Non-underlying
items within operating profit
|
129
|
207
|
Non-underlying
items not in operating profit but within net profit
|
90
|
12
|
Taxation before tax impact of non-underlying items
|
2,719
|
2,418
|
Profit before taxation
|
8,869
|
9,339
|
Share of net profit of joint ventures and associates
|
(255)
|
(231)
|
Profit before tax excluding share of net profit of joint ventures
and associates
|
8,614
|
9,108
|
Non-underlying items within operating profit before
tax
|
1,779
|
173
|
Non-underlying items not in operating profit but within net profit
before tax
|
155
|
153
|
Profit before tax excluding non-underlying items before tax and
share of net profit of joint ventures and associates
|
10,548
|
9,434
|
Effective tax rate (%)
|
29.0
|
24.1
|
Underlying effective tax rate (%)
|
25.8
|
25.6
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Net profit
|
6,369
|
7,140
|
Non-controlling interest
|
(625)
|
(653)
|
Net profit attributable to shareholders' equity - used for basic
and diluted earnings per share
|
5,744
|
6,487
|
Post-tax impact of non-underlying items attributable to
shareholders' equity
|
1,736
|
101
|
Underlying profit attributable to shareholders' equity - used for
basic and diluted earnings per share
|
7,480
|
6,588
|
Adjusted average number of shares (millions of share
units)
|
2,507.1
|
2,532.4
|
Diluted EPS (€)
|
2.29
|
2.56
|
Underlying EPS - diluted (€)
|
2.98
|
2.60
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Underlying profit attributable to shareholders' equity
|
7,480
|
6,588
|
Impact of translation from current to constant exchange rates and
translational hedges
|
272
|
(45)
|
Impact of price growth in excess of 26% per year in
hyperinflationary economies
|
(274)
|
-
|
Constant underlying earnings attributable to shareholders'
equity
|
7,478
|
6,543
|
Diluted average number of share units (millions of
units)
|
2,507.1
|
2,532.4
|
Constant underlying EPS (€)
|
2.98
|
2.58
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Total financial liabilities
|
(32,053)
|
(29,622)
|
Current
financial liabilities
|
(6,987)
|
(5,087)
|
Non-current
financial liabilities
|
(25,066)
|
(24,535)
|
Cash and cash equivalents as per balance sheet
|
6,136
|
4,159
|
Cash
and cash equivalents as per cash flow statement
|
5,950
|
4,045
|
Add:
bank overdrafts deducted therein
|
180
|
116
|
Less:
cash and cash equivalents held for sale
|
6
|
(2)
|
Other current financial assets
|
1,330
|
1,731
|
Non-current financial asset derivatives that relate to financial
liabilities
|
68
|
75
|
Net debt
|
(24,519)
|
(23,657)
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Net profit
|
6,369
|
7,140
|
Net finance costs
|
604
|
486
|
Net monetary loss arising from hyperinflationary
economies
|
195
|
142
|
Share of net profit of joint ventures and associates
|
(255)
|
(231)
|
Other (income)/loss from non-current investments and
associates
|
(13)
|
22
|
Taxation
|
2,500
|
2,199
|
Operating profit
|
9,400
|
9,758
|
Depreciation and amortisation
|
1,624
|
1,578
|
Earnings before interest, taxes, depreciation and amortisation
(EBITDA)
|
11,024
|
11,336
|
Non-underlying items within operating profit
|
1,779
|
173
|
Underlying earnings before interest, taxes, depreciation and
amortisation (UEBITDA)
|
12,803
|
11,509
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Cash flow from operating activities
|
12,144
|
11,561
|
Income tax paid
|
(2,625)
|
(2,135)
|
Net capital expenditure
|
(1,934)
|
(1,703)
|
Net interest paid
|
(653)
|
(632)
|
Free cash flow
|
6,932
|
7,091
|
Net cash flow (used in)/from investing activities
|
(625)
|
(2,294)
|
Net cash flow used in financing activities
|
(6,941)
|
(7,193)
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Net profit
|
6,369
|
7,140
|
Loss/(gain) on disposal of group companies
|
406
|
(489)
|
Share of net profit of joint ventures and associates
|
(255)
|
(231)
|
Other (income)/loss from non-current investments and
associates
|
(13)
|
22
|
Tax on gain on disposal of group companies
|
140
|
(69)
|
Net profit excluding P&L on disposals, JV, associates,
NCI
|
6,647
|
6,373
|
Cash flow from operating activities
|
12,144
|
11,561
|
Free cash flow
|
6,932
|
7,091
|
Cash impact of tax on disposal
|
111
|
14
|
Free cash flow excluding cash impact of tax on
disposal
|
7,043
|
7,105
|
Cash conversion from operating activities (%)
|
191
|
162
|
Cash conversion (%)
|
106
|
111
|
€
million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Operating profit
|
9,400
|
9,758
|
Tax on operating profit(a)
|
(2,726)
|
(2,352)
|
Operating profit after tax
|
6,674
|
7,406
|
|
|
|
Operating profit
|
9,400
|
9,758
|
Non-underlying items within operating profit
|
1,779
|
173
|
Underlying operating profit before tax
|
11,179
|
9,931
|
Tax on underlying operating profit(b)
|
(2,882)
|
(2,545)
|
Underlying operating profit after tax
|
8,297
|
7,386
|
Goodwill
|
22,311
|
21,109
|
Intangible assets
|
18,590
|
18,357
|
Property, plant and equipment
|
11,669
|
10,707
|
Net assets held for sale
|
119
|
516
|
Inventories
|
5,177
|
5,119
|
Trade and other current receivables
|
6,011
|
5,775
|
Trade payables and other current liabilities
|
(16,690)
|
(16,857)
|
Period-end invested capital
|
47,187
|
44,726
|
Average invested capital for the period
|
45,957
|
45,487
|
Return on invested capital (%)
|
14.5
|
16.3
|
Underlying return on invested capital (%)
|
18.1
|
16.2
|
Cautionary Statement
|
Enquiries
|
Media: Media Relations Team
|
Investors: Investor
Relations Team
|
|||
UK
|
+44 78 2527 3767
|
|
|
|
or
|
+44 77 7999 9683
|
|
|
|
NL
|
+31 62 191 3705
|
|
|
|
or
|
+31 61 500 8293
|
|
|
|
Consolidated income statement
|
€ million
|
Full
Year
|
||
(unaudited)
|
2024
|
2023
|
Change
|
Turnover
|
60,761
|
59,604
|
1.9%
|
Operating profit
|
9,400
|
9,758
|
(3.7)%
|
Net finance costs
|
(604)
|
(486)
|
|
Pensions
and similar obligations
|
71
|
110
|
|
Finance
income
|
438
|
442
|
|
Finance
costs
|
(1,113)
|
(1,038)
|
|
Net monetary loss arising from hyperinflationary
economies
|
(195)
|
(142)
|
|
Share of net profit of joint ventures and associates
|
255
|
231
|
|
Other income/(loss) from non-current investments and
associates
|
13
|
(22)
|
|
Profit before taxation
|
8,869
|
9,339
|
(5.0)%
|
Taxation
|
(2,500)
|
(2,199)
|
|
Net profit
|
6,369
|
7,140
|
(10.8)%
|
|
|
|
|
Attributable to:
|
|
|
|
Non-controlling
interests
|
625
|
653
|
|
Shareholders'
equity
|
5,744
|
6,487
|
(11.5)%
|
Earnings per share
|
|
|
|
Basic earnings per share (euros)
|
2.30
|
2.58
|
(10.6)%
|
Diluted earnings per share (euros)
|
2.29
|
2.56
|
(10.6)%
|
Consolidated statement of comprehensive income
|
€ million
|
Full
Year
|
|
(unaudited)
|
2024
|
2023
|
Net profit
|
6,369
|
7,140
|
Other comprehensive income
|
|
|
Items that will not be reclassified to profit or loss, net of
tax:
|
|
|
Gains/(losses)
on equity instruments measured at fair value through other
comprehensive income
|
60
|
(28)
|
Remeasurement
of defined benefit pension plans
|
264
|
(510)
|
Items that may be reclassified subsequently to profit or loss, net
of tax:
|
|
|
Gains/(losses)
on cash flow hedges
|
210
|
(27)
|
Currency
retranslation gains/(losses)
|
1,389
|
(1,461)
|
Total comprehensive income
|
8,292
|
5,114
|
|
|
|
Attributable to:
|
|
|
Non-controlling interests
|
712
|
524
|
Shareholders' equity
|
7,580
|
4,590
|
Consolidated statement of changes in equity
|
(unaudited)
|
|
|
|
|
|
|
|
|
€ million
|
Called
up
share
capital
|
Share
premium
account
|
Unification
reserve
|
Other
reserves
|
Retained
profit
|
Total
|
Non-
controlling
interest
|
Total
equity
|
1 January 2023
|
92
|
52,844
|
(73,364)
|
(10,804)
|
50,253
|
19,021
|
2,680
|
21,701
|
Profit or loss for the period
|
-
|
-
|
-
|
-
|
6,487
|
6,487
|
653
|
7,140
|
Other comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
Losses on:
|
|
|
|
|
|
|
|
|
Equity
instruments
|
-
|
-
|
-
|
(27)
|
-
|
(27)
|
(1)
|
(28)
|
Cash
flow hedges
|
-
|
-
|
-
|
(27)
|
-
|
(27)
|
-
|
(27)
|
Remeasurements of defined benefit pension plans
|
-
|
-
|
-
|
-
|
(508)
|
(508)
|
(2)
|
(510)
|
Currency retranslation (losses)/gains(a)
|
-
|
-
|
-
|
(1,629)
|
294
|
(1,335)
|
(126)
|
(1,461)
|
Total comprehensive income
|
-
|
-
|
-
|
(1,683)
|
6,273
|
4,590
|
524
|
5,114
|
Dividends on ordinary capital
|
-
|
-
|
-
|
-
|
(4,327)
|
(4,327)
|
-
|
(4,327)
|
Cancellation of treasury shares(b)
|
(4)
|
-
|
-
|
5,282
|
(5,278)
|
-
|
-
|
-
|
Repurchase of shares(c)
|
-
|
-
|
-
|
(1,507)
|
-
|
(1,507)
|
-
|
(1,507)
|
Movements in treasury shares(d)
|
-
|
-
|
-
|
75
|
(98)
|
(23)
|
-
|
(23)
|
Share-based payment credit(e)
|
-
|
-
|
-
|
-
|
212
|
212
|
-
|
212
|
Dividends paid to non-controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
(521)
|
(521)
|
Hedging (gain)/loss transferred to non-financial
assets
|
-
|
-
|
-
|
117
|
-
|
117
|
-
|
117
|
Other movements in equity
|
-
|
-
|
-
|
2
|
17
|
19
|
(21)
|
(2)
|
31 December 2023
|
88
|
52,844
|
(73,364)
|
(8,518)
|
47,052
|
18,102
|
2,662
|
20,764
|
Profit or loss for the period
|
-
|
-
|
-
|
-
|
5,744
|
5,744
|
625
|
6,369
|
Other comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
Gains on:
|
|
|
|
|
|
|
|
|
Equity
instruments
|
-
|
-
|
-
|
60
|
-
|
60
|
-
|
60
|
Cash
flow hedges
|
-
|
-
|
-
|
210
|
-
|
210
|
-
|
210
|
Remeasurements of defined benefit pension plans
|
-
|
-
|
-
|
-
|
269
|
269
|
(5)
|
264
|
Currency retranslation gains(a)
|
-
|
-
|
-
|
406
|
891
|
1,297
|
92
|
1,389
|
Total comprehensive income
|
-
|
-
|
-
|
676
|
6,904
|
7,580
|
712
|
8,292
|
Dividends on ordinary capital
|
-
|
-
|
-
|
-
|
(4,320)
|
(4,320)
|
-
|
(4,320)
|
Cancellation of treasury shares
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Repurchase of shares(c)
|
-
|
-
|
-
|
(1,508)
|
-
|
(1,508)
|
-
|
(1,508)
|
Movements in treasury shares(d)
|
-
|
-
|
-
|
25
|
(120)
|
(95)
|
-
|
(95)
|
Share-based payment credit(e)
|
-
|
-
|
-
|
-
|
324
|
324
|
-
|
324
|
Dividends paid to non-controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
(712)
|
(712)
|
Hedging (gain)/loss transferred to non-financial
assets
|
-
|
-
|
-
|
(54)
|
-
|
(54)
|
-
|
(54)
|
Other movements in equity
|
-
|
-
|
-
|
80
|
(119)
|
(39)
|
(97)
|
(136)
|
31 December 2024
|
88
|
52,844
|
(73,364)
|
(9,299)
|
49,721
|
19,990
|
2,565
|
22,555
|
Consolidated balance sheet
|
(unaudited)
|
|
|
€ million
|
As
at 31
December
2024
|
As
at 31
December
2023
|
Non-current assets
|
|
|
Goodwill
|
22,311
|
21,109
|
Intangible assets
|
18,590
|
18,357
|
Property, plant and equipment
|
11,669
|
10,707
|
Pension asset for funded schemes in surplus
|
4,164
|
3,781
|
Deferred tax assets
|
1,280
|
1,113
|
Financial assets
|
1,571
|
1,386
|
Other non-current assets
|
971
|
911
|
|
60,556
|
57,364
|
Current assets
|
|
|
Inventories
|
5,177
|
5,119
|
Trade and other current receivables
|
6,011
|
5,775
|
Current tax assets
|
373
|
427
|
Cash and cash equivalents
|
6,136
|
4,159
|
Other financial assets
|
1,330
|
1,731
|
Assets held for sale
|
167
|
691
|
|
19,194
|
17,902
|
|
|
|
Total assets
|
79,750
|
75,266
|
|
|
|
Current liabilities
|
|
|
Financial liabilities
|
6,987
|
5,087
|
Trade payables and other current liabilities
|
16,690
|
16,857
|
Current tax liabilities
|
678
|
851
|
Provisions
|
831
|
537
|
Liabilities held for sale
|
48
|
175
|
|
25,234
|
23,507
|
Non-current liabilities
|
|
|
Financial liabilities
|
25,066
|
24,535
|
Non-current tax liabilities
|
585
|
384
|
Pensions and post-retirement healthcare liabilities:
|
|
|
Funded
schemes in deficit
|
173
|
351
|
Unfunded
schemes
|
1,021
|
1,029
|
Provisions
|
571
|
563
|
Deferred tax liabilities
|
4,342
|
3,995
|
Other non-current liabilities
|
203
|
138
|
|
31,961
|
30,995
|
|
|
|
Total liabilities
|
57,195
|
54,502
|
|
|
|
Equity
|
|
|
Shareholders' equity
|
19,990
|
18,102
|
Non-controlling interests
|
2,565
|
2,662
|
Total equity
|
22,555
|
20,764
|
|
|
|
Total liabilities and equity
|
79,750
|
75,266
|
Consolidated cash flow statement
|
(unaudited)
|
Full
Year
|
|
€ million
|
2024
|
2023
|
Net profit
|
6,369
|
7,140
|
Taxation
|
2,500
|
2,199
|
Share of net profit of joint ventures/associates and other
(income)/loss from non-current investments and
associates
|
(268)
|
(209)
|
Net monetary loss arising from hyperinflationary
economies
|
195
|
142
|
Net finance costs
|
604
|
486
|
Operating profit
|
9,400
|
9,758
|
|
|
|
Depreciation, amortisation and impairment
|
1,757
|
1,579
|
Changes in working capital
|
(160)
|
814
|
Inventories
|
(198)
|
340
|
Trade
and other receivables
|
(206)
|
768
|
Trade
payables and other liabilities
|
244
|
(294)
|
Pensions and similar obligations less payments
|
(88)
|
(281)
|
Provisions less payments
|
330
|
(185)
|
Elimination of loss/(profits) on disposals
|
436
|
(433)
|
Non-cash charge for share-based compensation
|
324
|
212
|
Other adjustments
|
145
|
97
|
Cash flow from operating activities
|
12,144
|
11,561
|
Income tax paid
|
(2,625)
|
(2,135)
|
Net cash flow from operating activities
|
9,519
|
9,426
|
|
|
|
Interest received
|
432
|
267
|
Purchase of intangible assets
|
(233)
|
(243)
|
Purchase of property, plant and equipment
|
(1,738)
|
(1,502)
|
Disposal of property, plant and equipment
|
37
|
42
|
Acquisition of businesses and investments in joint ventures and
associates
|
(795)
|
(704)
|
Disposal of businesses, joint ventures and associates
|
985
|
436
|
Acquisition of other non-current investments
|
(166)
|
(533)
|
Disposal of other non-current investments
|
59
|
62
|
Dividends from joint ventures, associates and other non-current
investments
|
261
|
239
|
Sale/(purchase) of financial assets
|
533
|
(358)
|
Net cash flow used in investing activities
|
(625)
|
(2,294)
|
|
|
|
Dividends paid on ordinary share capital
|
(4,319)
|
(4,363)
|
Interest paid
|
(1,085)
|
(899)
|
Net change in short-term borrowings
|
643
|
(570)
|
Additional financial liabilities
|
4,741
|
4,972
|
Repayment of financial liabilities
|
(4,306)
|
(3,905)
|
Capital element of lease rental payments
|
(381)
|
(394)
|
Repurchase of shares
|
(1,508)
|
(1,507)
|
Other financing activities
|
(726)
|
(527)
|
Net cash flow used in financing activities
|
(6,941)
|
(7,193)
|
|
|
|
Net increase/(decrease) in cash and cash equivalents
|
1,953
|
(61)
|
|
|
|
Cash and cash equivalents at the beginning of the
period
|
4,045
|
4,225
|
|
|
|
Effect of foreign exchange rate changes
|
(48)
|
(119)
|
|
|
|
Cash and cash equivalents at the end of the period
|
5,950
|
4,045
|
Notes to the condensed consolidated financial
statements
|
1.
Accounting information and policies
|
2.
Segment information - Business Groups
|
Fourth Quarter
|
Personal
Care
|
Home
Care
|
Foods
|
Ice
Cream
|
Total
|
|
Turnover (€ million)
|
|
|
|
|
|
|
2023
|
3,181
|
3,404
|
2,974
|
3,416
|
1,202
|
14,177
|
2024
|
3,310
|
3,235
|
2,960
|
3,434
|
1,223
|
14,162
|
Change (%)
|
4.1
|
(5.0)
|
(0.5)
|
0.5
|
1.8
|
(0.1)
|
Full Year
|
Beauty
&
Wellbeing
|
Personal
Care
|
Home
Care
|
Foods
|
Ice
Cream
|
Total
|
Turnover (€ million)
|
|
|
|
|
|
|
2023
|
12,466
|
13,829
|
12,181
|
13,204
|
7,924
|
59,604
|
2024
|
13,157
|
13,618
|
12,352
|
13,352
|
8,282
|
60,761
|
Change (%)
|
5.5
|
(1.5)
|
1.4
|
1.1
|
4.5
|
1.9
|
|
|
|
|
|
|
|
Operating profit (€ million)
|
|
|
|
|
|
|
2023
|
2,209
|
2,957
|
1,419
|
2,413
|
760
|
9,758
|
2024
|
1,970
|
2,739
|
1,521
|
2,599
|
571
|
9,400
|
Underlying operating profit (€ million)
|
|
|
|
|
|
|
2023
|
2,331
|
2,792
|
1,496
|
2,460
|
852
|
9,931
|
2024
|
2,552
|
3,014
|
1,785
|
2,847
|
981
|
11,179
|
3.
Segment information - Geographical area
|
Fourth Quarter
|
Asia
Pacific
Africa
|
The
Americas
|
Europe
|
Total
|
Turnover (€ million)
|
|
|
|
|
2023
|
6,119
|
5,388
|
2,670
|
14,177
|
2024
|
5,988
|
5,453
|
2,721
|
14,162
|
Change (%)
|
(2.1)
|
1.2
|
1.9
|
(0.1)
|
Full Year
|
Asia
Pacific
Africa
|
The
Americas
|
Europe
|
Total
|
Turnover (€ million)
|
|
|
|
|
2023
|
26,234
|
21,531
|
11,839
|
59,604
|
2024
|
25,991
|
22,491
|
12,279
|
60,761
|
Change (%)
|
(0.9)
|
4.5
|
3.7
|
1.9
|
4.
Taxation
|
5.
Earnings per share
|
|
Full
Year
|
|
|
2024
|
2023
|
EPS - Basic
|
|
|
Net profit attributable to shareholders' equity (€
million)
|
5,744
|
6,487
|
Average number of shares (millions of share units)
|
2,492.6
|
2,515.9
|
EPS - basic (€)
|
2.30
|
2.58
|
|
|
|
EPS - Diluted
|
|
|
Net profit attributable to shareholders' equity (€
million)
|
5,744
|
6,487
|
Adjusted average number of shares (millions of share
units)
|
2,507.1
|
2,532.4
|
EPS - diluted (€)
|
2.29
|
2.56
|
|
Millions
|
Number of shares at 31 December 2023 (net of treasury
shares)
|
2,499.0
|
Shares repurchased under the share buyback programme
|
(27.4)
|
Net movements in shares under incentive schemes
|
4.0
|
Number of shares at 31 December 2024 (net of treasury
shares)
|
2,475.6
|
6.
Acquisitions and disposals
|
Deal completion date
|
Acquired/disposed business
|
1 February 2024
|
Acquired 91.88% of K18, a U.S. based premium hair care brand. The
acquisition complements Unilever's existing Beauty and Wellbeing
portfolio, with a range of high-quality, hair care
products.
|
1 June 2024
|
Sold Elida Beauty to Yellow Wood Partners LLC. Elida Beauty
comprises more than 20 beauty and personal care brands, such as
Q-Tips, Caress, Timotei and TIGI.
|
1 August 2024
|
Sold Qinyuan Group (also known as "Truliva") to Yong Chao Venture
Capital Co., Ltd. Qinyuan Group offers a range of water
purification solutions to households in China.
|
8 October 2024
|
Sold the Russian subsidiary to Arnest Group. The sale includes all
of Unilever's business in Russia and its four factories in the
country, along with our business in Belarus.
|
1 November 2024
|
Sold Pureit to A.O. Smith. Pureit offers a range of water
purification solutions across India, Bangladesh, Sri Lanka, Vietnam
and Mexico, among others.
|
€ million
|
Total
2024
|
Intangible assets
|
382
|
Other non-current assets
|
14
|
Trade and other receivables
|
15
|
Other current assets
|
36
|
Non-current liabilities(a)
|
(99)
|
Current liabilities
|
(15)
|
Net assets acquired
|
333
|
Non-controlling interest
|
(27)
|
Goodwill
|
310
|
Total consideration
|
616
|
Of which:
|
|
Cash
consideration paid
|
616
|
Deferred
consideration
|
-
|
€ million
|
2024
|
2023
|
Goodwill and intangible assets(a)
|
1,107
|
56
|
Other non-current assets
|
218
|
55
|
Current assets(b)
|
700
|
108
|
Liabilities(c)
|
(683)
|
(144)
|
Net assets sold
|
1,342
|
75
|
Loss on recycling of currency retranslation on
disposal
|
545
|
14
|
Non-controlling interest
|
(85)
|
-
|
Profit/(loss) on sale attributable to Unilever
|
(406)
|
489
|
Consideration
|
1,396
|
578
|
Of which:
|
|
|
Cash(d)
|
1,299
|
477
|
Non-cash
items and deferred consideration
|
97
|
101
|
7.
Share buyback
|
8.
Financial instruments
|
|
31
December 2024
|
31
December 2023
|
||||
€ million
|
Current
|
Non-current
|
Total
|
Current
|
Non-current
|
Total
|
Cash and cash equivalents
|
|
|
|
|
|
|
Cash
at bank and in hand
|
3,241
|
-
|
3,241
|
2,862
|
-
|
2,862
|
Short-term deposits(a)
|
2,436
|
-
|
2,436
|
1,181
|
-
|
1,181
|
Other cash equivalents(b)
|
459
|
-
|
459
|
116
|
-
|
116
|
|
6,136
|
-
|
6,136
|
4,159
|
-
|
4,159
|
Other financial assets
|
|
|
|
|
|
|
Financial assets at amortised
cost(c)
|
736
|
526
|
1,262
|
961
|
454
|
1,415
|
Financial assets at fair value through other
comprehensive income(d)
|
-
|
600
|
600
|
151
|
458
|
609
|
Financial
assets at fair value through profit or loss:
|
|
|
|
|
|
|
Derivatives
|
149
|
68
|
217
|
37
|
75
|
112
|
Other(e)
|
445
|
377
|
822
|
582
|
399
|
981
|
|
1,330
|
1,571
|
2,901
|
1,731
|
1,386
|
3,117
|
Total financial assets(f)
|
7,466
|
1,571
|
9,037
|
5,890
|
1,386
|
7,276
|
|
Fair
value
|
Carrying
amount
|
||
€ million
|
As
at 31 December 2024
|
As
at 31 December 2023
|
As
at 31 December 2024
|
As
at 31 December 2023
|
Financial assets
|
|
|
|
|
Cash and cash equivalents
|
6,136
|
4,159
|
6,136
|
4,159
|
Financial assets at amortised cost
|
1,262
|
1,415
|
1,262
|
1,415
|
Financial assets at fair value through other comprehensive
income
|
600
|
609
|
600
|
609
|
Financial assets at fair value through profit and
loss:
|
|
|
|
|
Derivatives
|
217
|
112
|
217
|
112
|
Other
|
822
|
981
|
822
|
981
|
|
9,037
|
7,276
|
9,037
|
7,276
|
Financial liabilities
|
|
|
|
|
Bank loans and overdrafts
|
(521)
|
(506)
|
(521)
|
(506)
|
Bonds and other loans
|
(28,037)
|
(26,112)
|
(28,648)
|
(26,692)
|
Lease liabilities
|
(1,486)
|
(1,395)
|
(1,486)
|
(1,395)
|
Derivatives
|
(594)
|
(494)
|
(594)
|
(494)
|
Other financial liabilities
|
(804)
|
(535)
|
(804)
|
(535)
|
|
(31,442)
|
(29,042)
|
(32,053)
|
(29,622)
|
|
As
at 31 December 2024
|
As
at 31 December 2023
|
||||
€ million
|
Level
1
|
Level
2
|
Level
3
|
Level
1
|
Level
2
|
Level
3
|
Assets at fair value
|
|
|
|
|
|
|
Financial assets at fair value through other comprehensive
income
|
10
|
4
|
586
|
163
|
4
|
442
|
Financial assets at fair value through profit or loss:
|
|
|
|
|
|
|
Derivatives(a)
|
-
|
420
|
-
|
-
|
149
|
-
|
Other
|
445
|
-
|
377
|
582
|
-
|
399
|
Liabilities at fair value
|
|
|
|
|
|
|
Derivatives(b)
|
-
|
(650)
|
-
|
-
|
(559)
|
-
|
Contingent
consideration
|
-
|
-
|
(1)
|
-
|
-
|
(157)
|
9.
Dividends
|
Per Unilever PLC ordinary share (traded on the London Stock
Exchange):
|
£0.3775
|
Per Unilever PLC ordinary share (traded on Euronext in
Amsterdam):
|
€0.4528
|
Per Unilever PLC American Depositary Receipt:
|
US$0.4674
|
|
Announcement
Date
|
Ex-dividend Date for
Ordinary Shares
|
Ex-dividend Date for
ADRs
|
Record Date
|
Last Date for DRIP
Election
|
Payment Date
|
Q4 2024 Dividend
|
13 February 2025
|
27 February 2025
|
28 February 2025
|
28 February 2025
|
07 March 2025
|
28 March 2025
|
Q1 2025 Dividend
|
24 April 2025
|
15 May 2025
|
16 May 2025
|
16 May 2025
|
22 May 2025
|
13 June 2025
|
Q2 2025 Dividend
|
31 July 2025
|
14 August 2025
|
15 August 2025
|
15 August 2025
|
21 August 2025
|
12 September 2025
|
Q3 2025 Dividend
|
23 October 2025
|
06 November 2025
|
07 November 2025
|
07 November 2025
|
14 November 2025
|
05 December 2025
|
10.
Events after the balance sheet date
|